Gait, physical activity and tibiofemoral cartilage damage: a longitudinal machine learning analysis in the Multicenter Osteoarthritis Study.

"Competing interests: NAS reports personal fees from Tenex Health and grants from Pacira Bioscience, outside of the submitted work. AG is shareholder of BICL, LLC and consultant to Pfizer, AstraZeneca, Novartis, TissueGene, Regeneron and MerckSerono. FWR is shareholder of BICL, LLC and consultant to Grünenthal. All other authors have no competing interests to report."

"Funding: MOST is composed of four cooperative grants (DTF (BU)—AG18820, J.C. Torner (UI)—AG18832, CEL (UAB)—AG18947, and MCN (UCSF)—AG19069] funded by the National Institutes of Health (NIH), a branch of the Department of Health and Human Services, and conducted by MOST study investigators. Research reported in this publication was also supported under award numbers F32AR076907 (KEC), P30AR072571 (DTF), 1UL1TR001430 (DTF), R21AR074578 (SRJ), R03AG060272 (S.R. Jafarzadeh), K23AR063235 (CLL), R01HL159620 (VBK), R21CA253498 (VBK), and K01AR069720 (DK) from the National Institutes of Health and 17SDG33670323 (VBK) and 20SFRN35460031 (VBK) from the American Heart Association. KEC was also supported by an Investigator Award from the Rheumatology Research Foundation. The MOST publications committee reviewed this manuscript before submission. The National Institutes of Health, the American Heart Association, and the Rheumatology Research Foundation were not involved in study design, collection, analysis or interpretation of data, or the decision to submit this manuscript for publication."